scholarly journals Raised concentrations of aldehyde lipid peroxidation products in premature infants with chronic lung disease

1999 ◽  
Vol 80 (1) ◽  
pp. F21-F25 ◽  
Author(s):  
T. Ogihara ◽  
K. Hirano ◽  
T. Morinobu ◽  
H.-S. Kim ◽  
M. Hiroi ◽  
...  
Keyword(s):  
Lipid Peroxidation ◽  
Lung Disease ◽  
Premature Infants ◽  
Chronic Lung Disease ◽  
Lipid Peroxidation Products

scholarly journals Chronic Lung Disease (CLD) Significantly Increases the Utilization of Hospital Resources in Premature Infants 1216

1998 ◽  
Vol 43 ◽  
pp. 208-208
Author(s):  
George W Bugg ◽  
Ann D Critz ◽  
Mary B White ◽  
Reese H Clark
Keyword(s):  
Lung Disease ◽  
Premature Infants ◽  
Chronic Lung Disease ◽  
Hospital Resources

Closure of a secundum atrial septal defect in two infants with chronic lung disease using the Gore HELEX Septal Occluder

2015 ◽  
Vol 26 (1) ◽  
pp. 79-83 ◽  
Author(s):  
Matt E. Zussman ◽  
Grace Freire ◽  
Shawn D. Cupp ◽  
Gary E. Stapleton
Keyword(s):  
Atrial Septal Defect ◽  
Lung Disease ◽  
Premature Infants ◽  
Chronic Lung Disease ◽  
Septal Defect ◽  
Right Atrial ◽  
Secundum Atrial Septal Defect ◽  
Atrial Septal Defect Closure ◽  
Significant Clinical Improvement ◽  
Helex Septal Occluder

AbstractChildren with a secundum atrial septal defect are usually asymptomatic and are referred for elective closure after 3–4 years of age; however, in premature infants with chronic lung disease, bronchopulmonary dysplasia, or pulmonary hypertension, increased pulmonary blood flow secondary to a left-to-right atrial shunt, may exacerbate their condition. Closure of the atrial septal defect in these patients can result in significant clinical improvement. We report the cases of two premature infants with chronic lung disease, who underwent atrial septal defect closure with the Gore HELEX Septal Occluder and discuss the technical aspects of using the device in these patients and their clinical outcomes.

Chronic Lung Disease of Prematurity

PEDIATRICS ◽  
1985 ◽  
Vol 76 (4) ◽  
pp. 652-652
Author(s):  
JAMES B. SCHICK ◽  
BOYD W. GOETZMAN
Keyword(s):  
Lung Disease ◽  
Premature Infants ◽  
Chronic Lung Disease ◽  
Potential Usefulness ◽  
Maximal Response ◽  
Days Of Therapy ◽  
Different Types ◽  
Toxic Drugs

To the Editor.— The paper by Avery et al,1 further demonstrates the potential usefulness of corticosteroids in chronic lung disease of prematurity. However, initial reports in 1974 and 1975 met with criticism for the use of potentially toxic drugs in premature infants.2,3 In 1983 we retrospectively reviewed 23 infants with chronic lung disease of prematurity who received corticosteroids and identified distinct differences between responders and nonresponders which suggested different types of lung disease.4 Our responders all showed a greater than 30% decrease in AaPo2 by day 6 and showed maximal response by ten days of therapy.

Eosinophilia in premature infants: correlation with chronic lung disease

2010 ◽  
Vol 85 (10) ◽  
pp. 1232-1235 ◽  
Author(s):  
C. Yamamoto ◽  
T. Kojima ◽  
K. Hattori ◽  
S. Nogi ◽  
H. Imamura ◽  
...  
Keyword(s):  
Lung Disease ◽  
Premature Infants ◽  
Chronic Lung Disease

Tracheostomy in the Extremely Premature Neonate: A Multi-Institutional Study

2020 ◽  
Vol 162 (4) ◽  
pp. 559-565
Author(s):  
Kevin D. Pereira ◽  
Kevin Shaigany ◽  
Karen B. Zur ◽  
Carolyn M. Jenks ◽  
Diego A. Preciado ◽  
...  
Keyword(s):  
Lung Disease ◽  
Premature Infants ◽  
Gestational Age ◽  
Chronic Lung Disease ◽  
Neonatal Intensive Care ◽  
Premature Neonate ◽  
Neurodevelopmental Outcomes ◽  
Children's Hospitals ◽  
Children’S Hospitals ◽  
The Mean

Objective (1) To describe characteristics associated with tracheostomy placement and (2) to describe associated in-hospital morbidity in extremely premature infants. Study Design Pooled retrospective analysis of charts. Setting Academic children’s hospitals. Subjects and Methods The patient records of premature infants (23-28 weeks gestational age) who underwent tracheostomy between January 1, 2012, and December 31, 2017, were reviewed from 4 academic children’s hospitals. Demographics, procedural morbidity, feeding, respiratory, and neurodevelopmental outcomes at the time of transfer from the neonatal intensive care unit (NICU) were obtained. The contribution of baseline characteristics to mortality, neurodevelopmental, and feeding outcomes was also assessed. Results: The charts of 119 infants were included. The mean gestational age was 25.5 (95% confidence interval, 25.2-25.7) weeks. The mean birth weight was 712 (671-752) g. Approximately 50% was African American. The principal comorbidity was chronic lung disease (92.4%). Overall, 60.5% of the infants had at least 1 complication. At the time of transfer, most remained mechanically ventilated (94%) and dependent on a feeding tube (90%). Necrotizing enterocolitis increased the risk of feeding impairment ( P = .002) and death ( P = .03). Conclusions Tracheostomy in the extremely premature neonate is primarily performed for chronic lung disease. Complications occur frequently, with skin breakdown being the most common. Placement of a tracheostomy does not seem to mitigate the systemic morbidity associated with extreme prematurity.

Sign in / Sign up

Export Citation Format

Share Document